Description: Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, operates in the animal health industry primarily in Brazil. The company operates through Production Animals, Companion Animals, and International Operations segments. It manufactures and trades in medicines, including anti-inflammatories, antibiotics, anticoccidials, antimastitics, ectoparasiticides, endectocides, endoparasiticides, hemoparasiticides, inoculants, therapeutics, products for animal reproduction, and vaccines; and other veterinary products for cattle, swine, poultry, sheep, horses, and goats. The company also manufactures veterinary solutions for dogs and cats, such as anesthetics, sedatives, anti-inflammatory, antibiotic, antimicrobial, dermatological, ectoparasiticide, endoparasiticide, dermocosmetic, and otological products. In addition, it offers vaccines and other veterinary products for production and companion animals. The company was formerly known as A.H.N.S.P.E. Empreendimentos e Participações S.A. Ouro Fino Saúde Animal Participações S.A. was incorporated in 1987 and is headquartered in Cravinhos, Brazil.
Home Page: www.ourofinosaudeanimal.com
Rodovia Anhanguera SP 330
Cravinhos,
SP
14140-000
Brazil
Phone:
55 80 0941 2000
Officers
| Name | Title |
|---|---|
| Mr. Kleber Cesar Silveira Gomes | CEO & Member of Exec. Board |
| Mr. Marcelo Da Silva | CFO, Member of Exec. Board & Chief Investor Relations Officer |
| Angelo Melo | Director - Strategic Devel. & New Bus. |
| Bruno Menegazzo | Supervisor of the Investor Relations Area |
| Mr. Dolivar Coraucci Neto | Consultant |
Exchange: SA
Country: BR
Currency: Brazilian real (R$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 11.7841 |
| Price-to-Book MRQ: | 1.7395 |
| Price-to-Sales TTM: | 1.2323 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 17952 |